151 related articles for article (PubMed ID: 468310)
21. Detection of soluble immune complexes by the technique of ADCC inhibition in human diseases.
Meyer O; Descamps B
J Clin Lab Immunol; 1979 Nov; 2(4):311-8. PubMed ID: 537026
[TBL] [Abstract][Full Text] [Related]
22. The antibody-dependent cell-mediated cytotoxic (ADCC) reaction. III. Lymphocyte, neutrophil and monocyte cytotoxic activity as a function of the alloantibodies and erythrocyte target cells in the human allogeneic ADCC assay.
Richter M; Richter M; Sklar S
Clin Invest Med; 1983; 6(1):19-24. PubMed ID: 6831791
[TBL] [Abstract][Full Text] [Related]
23. Antibody dependent cellular cytotoxicity (ADCC) against human erythrocytes, mediated by blood group alloantibodies: a model for the role of antigen density in target cell lysis.
Northoff H; Kluge A; Resch K
Z Immunitatsforsch Immunobiol; 1978; 154(1):15-33. PubMed ID: 74918
[TBL] [Abstract][Full Text] [Related]
24. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
Nonomura A; Shintani T; Ohta G
Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
[TBL] [Abstract][Full Text] [Related]
25. Immunological studies on Crohn's disease. IV. Decreased ADCC activity.
Okabe N; Fujita K; Takenaka K; Yao T
J Clin Lab Immunol; 1986 Feb; 19(2):77-81. PubMed ID: 3485720
[TBL] [Abstract][Full Text] [Related]
26. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
28. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of antibody-dependent cellular cytotoxicity (ADCC) by normal and pathological sera from patients with advanced lung cancer.
Fekete B; Sachno L; Tamássy K; Pál A; Angyal I; Forrai I
Haematologia (Budap); 1981 Dec; 14(4):417-23. PubMed ID: 7344976
[TBL] [Abstract][Full Text] [Related]
30. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
Poston RN; Morgan RS
Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
[TBL] [Abstract][Full Text] [Related]
31. Serum IgE levels in patients with inflammatory bowel disease.
Levo Y; Shalit M; Wollner S; Fich A
Ann Allergy; 1986 Jan; 56(1):85-7. PubMed ID: 3946842
[TBL] [Abstract][Full Text] [Related]
32. Effect of rheumatoid factors and normal human sera on immune complex-Fc gamma R interaction.
Isturiz MA; Giordano M; Serebrinsky GP
Clin Exp Immunol; 1983 Oct; 54(1):225-31. PubMed ID: 6225582
[TBL] [Abstract][Full Text] [Related]
33. An evaluation under code of new techniques for the detection of cytomegalovirus antibodies: sensitivity of assays and importance of immune complexes.
Cheung KS; Roche JK; Capel WD; Lang DJ
J Clin Lab Immunol; 1981 Nov; 6(3):269-74. PubMed ID: 6279849
[TBL] [Abstract][Full Text] [Related]
34. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
Kemler BJ; Alpert E
Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Ebert EC; Geng X; Lin J; Das KM
Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of cytotoxic effector cells and antibody producing cells from human intestine.
MacDermott RP
Acta Chir Scand Suppl; 1985; 525():25-43. PubMed ID: 3875204
[TBL] [Abstract][Full Text] [Related]
37. Antigen-antibody complexes in inflammatory bowel disease.
Danis VA; Harries AD; Heatley RV
Scand J Gastroenterol; 1984 Jul; 19(5):603-6. PubMed ID: 6474081
[TBL] [Abstract][Full Text] [Related]
38. Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis).
Haslam PL; Allan F; Watling AF; Barrett C; Morris L; Turner-Warwick M
Clin Exp Immunol; 1982 Jul; 49(1):59-66. PubMed ID: 7127903
[TBL] [Abstract][Full Text] [Related]
39. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies.
Rumpold H; Wiedermann G; Scheiner O; Kraft D; Stemberger H
Immunology; 1981 May; 43(1):161-70. PubMed ID: 6788680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
